You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

Article metrics

Article menu
Basic tumor immunology
Original research
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

 

Online download statistics by month:

Online download statistics by month: March 2023 to July 2025

AbstractFullPdf
Mar 2023549560183
Apr 2023368370184
May 2023212214101
Jun 202311812246
Jul 202312913244
Aug 202314114232
Sep 202313813952
Oct 202310810843
Nov 202312813059
Dec 2023959649
Jan 2024939362
Feb 2024878848
Mar 2024126126104
Apr 202410510559
May 2024929346
Jun 2024908950
Jul 2024868843
Aug 2024454326
Sep 2024747554
Oct 2024808053
Nov 2024555627
Dec 202411712048
Jan 2025919141
Feb 202522522648
Mar 2025666741
Apr 2025989853
May 2025666856
Jun 2025474734
Jul 2025110
Total363036671686